SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 133 filers reported holding SANA BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $165,249 | -54.2% | 42,700 | -29.4% | 0.00% | -100.0% |
| Q2 2023 | $360,580 | +82.6% | 60,500 | +0.2% | 0.00% | 0.0% |
| Q1 2023 | $197,508 | +17.9% | 60,400 | +42.5% | 0.00% | – |
| Q4 2022 | $167,480 | -53.6% | 42,400 | -29.6% | 0.00% | -100.0% |
| Q3 2022 | $361,000 | -33.3% | 60,200 | -28.5% | 0.00% | -50.0% |
| Q2 2022 | $541,000 | -42.0% | 84,200 | -25.4% | 0.00% | 0.0% |
| Q1 2022 | $933,000 | +188.0% | 112,900 | +440.2% | 0.00% | +100.0% |
| Q4 2021 | $324,000 | – | 20,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 34,239,018 | $673,139,000 | 8.60% |
| Trustees of Columbia University in the City of New York | 281,250 | $5,530,000 | 8.17% |
| Crestline Management, LP | 3,210,937 | $63,127,000 | 5.44% |
| Omega Fund Management, LLC | 843,750 | $16,588,000 | 1.88% |
| Alphabet Inc. | 2,812,500 | $55,294,000 | 1.13% |
| SB Management Ltd | 2,625,153 | $51,611,000 | 0.61% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 4,508,111 | $88,629,000 | 0.53% |
| HARVARD MANAGEMENT CO INC | 468,749 | $9,216,000 | 0.53% |
| Avidity Partners Management LP | 778,597 | $15,307,000 | 0.41% |
| Dragoneer Investment Group | 1,500,000 | $29,490,000 | 0.38% |